Current and future options for opioid use disorder: a survey assessing real-world opinion of service users on novel therapies including depot formulations of buprenorphine

PURPOSE: Integrated treatment for opioid use disorder (OUD) includes opioid agonist therapy (OAT) such as methadone and buprenorphine with well-evidenced benefits. Treatment with typical existing oral medications is associated with burdens and limits to successful outcomes (frequent dosing, attendan...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilman, Mark, Li, Li, Hudson, Kerrie, Lumley, Tara, Myers, Georgia, Corte, Camilla, Littlewood, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188959/
https://www.ncbi.nlm.nih.gov/pubmed/30349206
http://dx.doi.org/10.2147/PPA.S180641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188959/
https://www.ncbi.nlm.nih.gov/pubmed/30349206
http://dx.doi.org/10.2147/PPA.S180641

Ejemplares similares